US0043971052 - Common Stock
ACCURAY INC
NASDAQ:ARAY (3/27/2024, 8:00:08 PM)
After market: 2.48 +0.05 (+2.06%)2.43
+0.06 (+2.53%)
Accuray, Inc. is a radiation oncology company. The company is headquartered in Madison, Wisconsin and currently employs 1,024 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.
ACCURAY INC
1240 Deming Way
Madison WISCONSIN 94089
P: 16088242800
CEO: Joshua H. Levine
Employees: 1024
Website: https://www.accuray.com/
/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery Society Meeting in Chicago, Illinois...
/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference...
While these under $5 stocks may be low priced, there’s nothing fundamentally cheap about these compelling enterprises.
Roth MKM initiated coverage of Accuray (ARAY) with a buy rating, citing the company’s expansion into emerging markets such as China and India. Read more here.
Here you can normally see the latest stock twits on ARAY, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: